Compare $DCOY vs $GRI | Chartloom

Compare

$DCOY vs $GRI

Decoy Therapeutics Inc · GRI Bio Inc

DCOY

Decoy Therapeutics Inc

GRI

GRI Bio Inc

Compare $DCOY vs $GRI

Comparing Decoy Therapeutics Inc and GRI Bio Inc

DCOYDecoy Therapeutics Inc

GRIGRI Bio Inc

DCOYDecoy Therapeutics Inc

Market cap

$779K

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-81.2%

52W performance

-97.0%

FCF yield

-1073.9%

GRIGRI Bio Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-77.8%

52W performance

-96.7%

FCF yield

-338.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DCOY

GRI

Detailed metrics comparison

DCOY

Decoy Therapeutics Inc

GRI

GRI Bio Inc

Market Cap

DCOY$779K

GRI$3M

Enterprise Value

DCOY$-8M

GRI$-8M

Price

DCOY$1.47

GRI$1.74

P/E Ratio

DCOYN/A

GRIN/A

P/S Ratio

DCOY3.42x

GRI0.00x

EV/Sales

DCOY-33.00x

GRI0.00x

EV/EBITDA

DCOY0.00x

GRI0.00x

P/B Ratio

DCOY0.75x

GRI0.42x

P/FCF Ratio

DCOYN/A

GRIN/A

EV/FCF

DCOY0.90x

GRI0.76x

PEG Ratio

DCOYN/A

GRIN/A

Forward P/E (NTM)

DCOYN/A

GRIN/A

Forward P/S (NTM)

DCOYN/A

GRIN/A

Revenue (TTM)

DCOY$228K

GRI$0

Revenue Growth (YoY)

DCOYN/A

GRIN/A

Forward Rev Growth

DCOY0.0%

GRI0.0%

Gross Margin (TTM)

DCOY48.6%

GRI0.0%

Operating Margin (TTM)

DCOY0.0%

GRI0.0%

EBITDA Margin (TTM)

DCOY-2668.9%

GRI0.0%

Net Margin (TTM)

DCOY-6348.7%

GRI0.0%

FCF Margin (TTM)

DCOY-3676.1%

GRIN/A

Net Income (TTM)

DCOY$-14M

GRI$-10M

FCF (TTM)

DCOY$-8M

GRI$-10M

EPS (TTM)

DCOY-$27.16

GRI-$5.35

ROE (TTM)

DCOY-31523.0%

GRI-13403.0%

ROA (TTM)

DCOY-16715.0%

GRI-10683.0%

ROIC (TTM)

DCOY-31523.0%

GRI-13403.0%

Cash

DCOY$8M

GRI$11M

Debt

DCOY$0

GRI$0

Net Cash/Debt

DCOY$8M

GRI$11M

Current Ratio (TTM)

DCOY1.83x

GRI10.30x

Quick Ratio (TTM)

DCOY1.77x

GRI9.95x

Debt/Equity (TTM)

DCOY0.00x

GRI0.00x

Debt/Assets (TTM)

DCOY0.0%

GRI0.0%

Interest Coverage (TTM)

DCOYN/A

GRIN/A

Net Debt/EBITDA (TTM)

DCOY0.00x

GRI0.00x

Beta

DCOY0.68

GRI-1.09

52W Performance

DCOY-97.0%

GRI-96.7%

YTD Performance

DCOY-81.2%

GRI-77.8%

% from 52W High

DCOY-97.4%

GRI-97.3%

% from 52W Low

DCOY0.7%

GRI27.9%

Asset Turnover (TTM)

DCOY0.03x

GRI0.00x

FCF Yield (TTM)

DCOY-1073.9%

GRI-338.3%

Earnings Yield (TTM)

DCOY-1854.7%

GRI-313.6%

Dividend Yield (TTM)

DCOYN/A

GRIN/A

Rule of 40

DCOY-3,676.1

GRI0.0

EV/GP/RG

DCOYN/A

GRIN/A

Ticker research

View DCOY research View GRI research

Metric	DCOY Decoy Therapeutics Inc	GRI GRI Bio Inc
Market & Valuation
Market Cap	$779K	$3M
Enterprise Value	$-8M	$-8M
Price	$1.47	$1.74
P/E Ratio	N/A	N/A
P/S Ratio	3.42x	0.00x
EV/Sales	-33.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.75x	0.42x
P/FCF Ratio	N/A	N/A
EV/FCF	0.90x	0.76x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$228K	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	48.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2668.9%	0.0%
Net Margin (TTM)	-6348.7%	0.0%
FCF Margin (TTM)	-3676.1%	N/A
Net Income (TTM)	$-14M	$-10M
FCF (TTM)	$-8M	$-10M
EPS (TTM)	-$27.16	-$5.35
ROE (TTM)	-31523.0%	-13403.0%
ROA (TTM)	-16715.0%	-10683.0%
ROIC (TTM)	-31523.0%	-13403.0%
Financial Health
Cash	$8M	$11M
Debt	$0	$0
Net Cash/Debt	$8M	$11M
Current Ratio (TTM)	1.83x	10.30x
Quick Ratio (TTM)	1.77x	9.95x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	-1.09
52W Performance	-97.0%	-96.7%
YTD Performance	-81.2%	-77.8%
% from 52W High	-97.4%	-97.3%
% from 52W Low	0.7%	27.9%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.00x
FCF Yield (TTM)	-1073.9%	-338.3%
Earnings Yield (TTM)	-1854.7%	-313.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,676.1	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DCOY research	View GRI research

Valuation

P/S Ratio

GRI

0.00x

DCOY

3.42x

EV/FCF

GRI

0.76x

DCOY

0.90x

Growth & revenue

Forward Revenue Growth

DCOY

0.0%

GRI

0.0%

Profitability & performance

Gross Margin

DCOY

48.6%

GRI

0.0%

ROE

GRI

-13403.0%

DCOY

-31523.0%

FCF Yield %

GRI

-338.3%

DCOY

-1073.9%

52-Week Performance

GRI

-96.7%

DCOY

-97.0%

Detailed metrics comparison

DCOY

Decoy Therapeutics Inc

GRI

GRI Bio Inc

Market Cap

DCOY$779K

GRI$3M

Enterprise Value

DCOY$-8M

GRI$-8M

Price

DCOY$1.47

GRI$1.74

P/E Ratio

DCOYN/A

GRIN/A

P/S Ratio

DCOY3.42x

GRI0.00x

EV/Sales

DCOY-33.00x

GRI0.00x

EV/EBITDA

DCOY0.00x

GRI0.00x

P/B Ratio

DCOY0.75x

GRI0.42x

P/FCF Ratio

DCOYN/A

GRIN/A

EV/FCF

DCOY0.90x

GRI0.76x

PEG Ratio

DCOYN/A

GRIN/A

Forward P/E (NTM)

DCOYN/A

GRIN/A

Forward P/S (NTM)

DCOYN/A

GRIN/A

Revenue (TTM)

DCOY$228K

GRI$0

Revenue Growth (YoY)

DCOYN/A

GRIN/A

Forward Rev Growth

DCOY0.0%

GRI0.0%

Gross Margin (TTM)

DCOY48.6%

GRI0.0%

Operating Margin (TTM)

DCOY0.0%

GRI0.0%

EBITDA Margin (TTM)

DCOY-2668.9%

GRI0.0%

Net Margin (TTM)

DCOY-6348.7%

GRI0.0%

FCF Margin (TTM)

DCOY-3676.1%

GRIN/A

Net Income (TTM)

DCOY$-14M

GRI$-10M

FCF (TTM)

DCOY$-8M

GRI$-10M

EPS (TTM)

DCOY-$27.16

GRI-$5.35

ROE (TTM)

DCOY-31523.0%

GRI-13403.0%

ROA (TTM)

DCOY-16715.0%

GRI-10683.0%

ROIC (TTM)

DCOY-31523.0%

GRI-13403.0%

Cash

DCOY$8M

GRI$11M

Debt

DCOY$0

GRI$0

Net Cash/Debt

DCOY$8M

GRI$11M

Current Ratio (TTM)

DCOY1.83x

GRI10.30x

Quick Ratio (TTM)

DCOY1.77x

GRI9.95x

Debt/Equity (TTM)

DCOY0.00x

GRI0.00x

Debt/Assets (TTM)

DCOY0.0%

GRI0.0%

Interest Coverage (TTM)

DCOYN/A

GRIN/A

Net Debt/EBITDA (TTM)

DCOY0.00x

GRI0.00x

Beta

DCOY0.68

GRI-1.09

52W Performance

DCOY-97.0%

GRI-96.7%

YTD Performance

DCOY-81.2%

GRI-77.8%

% from 52W High

DCOY-97.4%

GRI-97.3%

% from 52W Low

DCOY0.7%

GRI27.9%

Asset Turnover (TTM)

DCOY0.03x

GRI0.00x

FCF Yield (TTM)

DCOY-1073.9%

GRI-338.3%

Earnings Yield (TTM)

DCOY-1854.7%

GRI-313.6%

Dividend Yield (TTM)

DCOYN/A

GRIN/A

Rule of 40

DCOY-3,676.1

GRI0.0

EV/GP/RG

DCOYN/A

GRIN/A

Ticker research

View DCOY research View GRI research

Metric	DCOY Decoy Therapeutics Inc	GRI GRI Bio Inc
Market & Valuation
Market Cap	$779K	$3M
Enterprise Value	$-8M	$-8M
Price	$1.47	$1.74
P/E Ratio	N/A	N/A
P/S Ratio	3.42x	0.00x
EV/Sales	-33.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.75x	0.42x
P/FCF Ratio	N/A	N/A
EV/FCF	0.90x	0.76x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$228K	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	48.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2668.9%	0.0%
Net Margin (TTM)	-6348.7%	0.0%
FCF Margin (TTM)	-3676.1%	N/A
Net Income (TTM)	$-14M	$-10M
FCF (TTM)	$-8M	$-10M
EPS (TTM)	-$27.16	-$5.35
ROE (TTM)	-31523.0%	-13403.0%
ROA (TTM)	-16715.0%	-10683.0%
ROIC (TTM)	-31523.0%	-13403.0%
Financial Health
Cash	$8M	$11M
Debt	$0	$0
Net Cash/Debt	$8M	$11M
Current Ratio (TTM)	1.83x	10.30x
Quick Ratio (TTM)	1.77x	9.95x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	-1.09
52W Performance	-97.0%	-96.7%
YTD Performance	-81.2%	-77.8%
% from 52W High	-97.4%	-97.3%
% from 52W Low	0.7%	27.9%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.00x
FCF Yield (TTM)	-1073.9%	-338.3%
Earnings Yield (TTM)	-1854.7%	-313.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,676.1	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DCOY research	View GRI research